NCT04040608

Brief Summary

Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
22mo left

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Mar 2021Mar 2028

First Submitted

Initial submission to the registry

July 26, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 31, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

March 2, 2021

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

7 years

First QC Date

July 26, 2019

Last Update Submit

February 11, 2026

Conditions

Keywords

visual analog scalestress

Outcome Measures

Primary Outcomes (2)

  • Visual analog scale to assess the perceived stress

    Visual analog scale to assess the perceived stress on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

    day 0

  • Visual analog scale to assess the perceived stress

    Visual analog scale to assess the perceived stress on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

    day 7

Secondary Outcomes (11)

  • Visual analog scale to assess anxiety

    day 0, day 7

  • Visual analog scale to assess sleep quality

    day 0, day 7

  • Visual analog scale to assess fatigue

    day 0, day 7

  • Job Demand-Control-Support (JDSC) questionnaire of Karasek

    day 0, day 7

  • The Effort-Reward Imbalance Questionnaire (ERI)

    day 0, day 7

  • +6 more secondary outcomes

Study Arms (1)

experimental group

differences in responses to visual analog scales depending on screen sizes

Other: Influence of screen sizes on responses to visual analog scales of stress

Interventions

An open questionnaire will be created by the Clinical Research Direction. The questionnaire will be opened by the examinator who will fulfill the anonymized identification of participants and the type of screens. In a dedicated room at the LaPSCo, the participants will answer the same VAS on four different sizes/types of screens (24-inch screen, laptop, tablet, smartphone) and on paper. Saliva will be collected after answering questionnaires. Heart rate variability and skin conductance will be measured with the use of a wrist watch during 15 minutes, from the entrance in the room to the completion of questionnaires. The participant will undergo the same examination within a week (15 minutes).

experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

healhy volunteers

You may qualify if:

  • Adult persons

You may not qualify if:

  • Refusal to participate in the study
  • Unable to answer basic questions (difficulties understanding, cognitive disorders…)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Clermont Ferrand

Clermont-Ferrand, 63003, France

RECRUITING

Study Officials

  • frédéric Dutheil

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2019

First Posted

July 31, 2019

Study Start

March 2, 2021

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations